These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25506455)

  • 21. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury.
    Liu Y; Li P; Wang F; Liu L; Zhang Y; Liu Y; Shi R
    Medicine (Baltimore); 2020 Oct; 99(41):e22259. PubMed ID: 33031266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing.
    González-Muñoz M; Monserrat Villatoro J; Marín-Serrano E; Stewart S; Bardón Rivera B; Marín J; Martínez de Soto L; Seco Meseguer E; Ramírez E
    Clin Case Rep; 2020 Dec; 8(12):3105-3109. PubMed ID: 33363890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation.
    Meunier L; Larrey D
    Front Pharmacol; 2019; 10():1482. PubMed ID: 31920666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rare case of cefepime-induced cholestatic liver injury.
    Liao PF; Wu YK; Huang KL; Chen HY
    Ci Ji Yi Xue Za Zhi; 2019; 31(2):124-128. PubMed ID: 31007494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carefully reviewing the history of diagnostic scales and paying more attention to the diagnostic value of Roussel - Uclaf causality assessment method scale for drug - induced liver injury].
    Chen CW
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):801-803. PubMed ID: 27978922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?
    Teschke R; Schmidt-Taenzer W; Wolff A
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
    Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
    Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation.
    Unger C; Al-Jashaami LS
    Am J Case Rep; 2016 Sep; 17():676-681. PubMed ID: 27653941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug induced liver injury: accuracy of diagnosis in published reports.
    Teschke R; Frenzel C; Wolff A; Eickhoff A; Schulze J
    Ann Hepatol; 2014; 13(2):248-55. PubMed ID: 24552867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
    Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albendazole-induced granulomatous hepatitis: a case report.
    Marin Zuluaga JI; Marin Castro AE; Perez Cadavid JC; Restrepo Gutierrez JC
    J Med Case Rep; 2013 Jul; 7():201. PubMed ID: 23889970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.
    Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A
    J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
    Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
    Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.
    Teschke R; Wolff A; Frenzel C; Schwarzenboeck A; Schulze J; Eickhoff A
    World J Hepatol; 2014 Jan; 6(1):17-32. PubMed ID: 24653791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone-Associated Severe Acute Hepatitis.
    Asif M; Khan WJ; Aslam S; Nadeem I; Singal AK
    Cureus; 2023 Mar; 15(3):e36341. PubMed ID: 37082506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute drug-induced hepatitis caused by albendazole.
    Choi GY; Yang HW; Cho SH; Kang DW; Go H; Lee WC; Lee YJ; Jung SH; Kim AN; Cha SW
    J Korean Med Sci; 2008 Oct; 23(5):903-5. PubMed ID: 18955802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
    Teschke R; Eickhoff A; Schulze J
    J Clin Transl Hepatol; 2013 Sep; 1(1):59-74. PubMed ID: 26357608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tools for causality assessment in drug-induced liver disease.
    Tillmann HL; Suzuki A; Barnhart HX; Serrano J; Rockey DC
    Curr Opin Gastroenterol; 2019 May; 35(3):183-190. PubMed ID: 30865042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.